Literature DB >> 15078732

Symptoms, respirator use, and pulmonary function changes among New York City firefighters responding to the World Trade Center disaster.

Debra M Feldman1, Sherry L Baron, Bruce P Bernard, Boris D Lushniak, Gisela Banauch, Nicole Arcentales, Kerry J Kelly, David J Prezant.   

Abstract

CONTEXT: New York City firefighters responding to the World Trade Center (WTC) disaster on September 11, 2001, were exposed to numerous hazards. A medical screening program was conducted 3 weeks after the disaster on a sample of firefighters.
OBJECTIVES: To determine whether arrival time at the WTC and other exposure variables (including respirator use) were associated with symptoms and changes in pulmonary function (after exposure - before exposure).
DESIGN: A cross-sectional comparison of firefighters representing the following groups: (1) firefighters who arrived before/during the WTC collapse, (2) firefighters who arrived 1 to 2 days after the collapse, (3) firefighters who arrived 3 to 7 days after the collapse, and (4) unexposed firefighters.
SETTING: Fire Department of New York City (FDNY) Bureau of Health Services on October 1 to 5, 2001. POPULATION: A stratified random sample of 362 of 398 recruited working firefighters (91%). Of these, 149 firefighters (41%) were present at the WTC collapse, 142 firefighters (39%) arrived after the collapse but within 48 h, 28 firefighters (8%) arrived 3 to 7 days after the collapse, and 43 firefighters (12%) were unexposed. MAIN OUTCOME MEASURES: New/worsening symptoms involving the eyes, skin, respiratory system, and nose and throat (NT), and changes in spirometry from before to after exposure.
RESULTS: During the first 2 weeks at the WTC site, 19% of study firefighters reported not using a respirator; 50% reported using a respirator but only rarely. Prevalence ratios (PRs) for skin, eye, respiratory, and NT symptoms showed a dose-response pattern between exposure groups based on time of arrival at the WTC site, with PRs between 2.6 and 11.4 with 95% confidence intervals (CIs) excluding 1.0 for all but skin symptoms. For those spending > 7 days at the site, the PR for respiratory symptoms was 1.32 (95% CI, 1.13 to 1.55), compared with those who were exposed for < 7 days. Mean spirometry results before and after exposure were within normal limits. The change in spirometry findings (after exposure - before exposure) showed near-equal reductions for FVC and FEV(1). These reductions were greater than the annual reductions measured in a referent population of incumbent FDNY firefighters prior to September 11 (p <or= 0.05). There was a 60% increased risk of a decline of >or= 450 mL in FEV(1) in those arriving during the first 48 h compared to the referent (p <or= 0.05).
CONCLUSIONS: The symptoms and pulmonary function changes following exposure at the WTC demonstrate the need for improvements in respirators and their use, as well as long-term medical monitoring of rescue workers.

Entities:  

Mesh:

Year:  2004        PMID: 15078732     DOI: 10.1378/chest.125.4.1256

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  41 in total

1.  Emerging exposures and respiratory health: World Trade Center dust.

Authors:  William N Rom; Joan Reibman; Linda Rogers; Michael D Weiden; Beno Oppenheimer; Kenneth Berger; Roberta Goldring; Denise Harrison; David Prezant
Journal:  Proc Am Thorac Soc       Date:  2010-05

Review 2.  Prevention of occupational asthma.

Authors:  Susan M Tarlo; Gary M Liss
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

3.  Occupational rhinosinusitis and upper airway disease: the world trade center experience.

Authors:  Rafael E de la Hoz; Michael R Shohet; Jeffrey M Cohen
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

4.  Lung function and health status in metropolitan fire-fighters compared to general population controls.

Authors:  Tjard Schermer; Trish Malbon; Michael Morgan; Nancy Briggs; Christine Holton; Sarah Appleton; Robbert Adams; Michael Smith; Alan Crockett
Journal:  Int Arch Occup Environ Health       Date:  2010-04-03       Impact factor: 3.015

5.  Lung Function Trajectories in World Trade Center-Exposed New York City Firefighters Over 13 Years: The Roles of Smoking and Smoking Cessation.

Authors:  Thomas K Aldrich; Madeline Vossbrinck; Rachel Zeig-Owens; Charles B Hall; Theresa M Schwartz; William Moir; Mayris P Webber; Hillel W Cohen; Anna Nolan; Michael D Weiden; Vasilios Christodoulou; Kerry J Kelly; David J Prezant
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

6.  Long term health complaints following the Amsterdam Air Disaster in police officers and fire-fighters.

Authors:  A C Huizink; P Slottje; A B Witteveen; J A Bijlsma; J W R Twisk; N Smidt; I Bramsen; W van Mechelen; H M van der Ploeg; L M Bouter; T Smid
Journal:  Occup Environ Med       Date:  2006-04-27       Impact factor: 4.402

7.  Pulmonary function after exposure to the World Trade Center collapse in the New York City Fire Department.

Authors:  Gisela I Banauch; Charles Hall; Michael Weiden; Hillel W Cohen; Thomas K Aldrich; Vasillios Christodoulou; Nicole Arcentales; Kerry J Kelly; David J Prezant
Journal:  Am J Respir Crit Care Med       Date:  2006-04-27       Impact factor: 21.405

8.  Respiratory protection programs for firefighters: a survey of practices for the state of Kentucky.

Authors:  Gregory H Easterling; Scott Prince
Journal:  Public Health Rep       Date:  2007 Nov-Dec       Impact factor: 2.792

9.  The influence of a disaster on the health of rescue workers: a longitudinal study.

Authors:  Mattijn Morren; Anja J E Dirkzwager; Frans J M Kessels; C Joris Yzermans
Journal:  CMAJ       Date:  2007-04-24       Impact factor: 8.262

10.  Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010.

Authors:  Jackie Soo; Mayris P Webber; Charles B Hall; Hillel W Cohen; Theresa M Schwartz; Kerry J Kelly; David J Prezant
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.